Suppr超能文献

去突触相关蛋白 95(PSD-95)后神经元型一氧化氮合酶(nNOS)的解离通过减少反应性星形胶质细胞中过度的紧张性 GABA 释放促进了小鼠脑缺血后的功能恢复。

Dissociation of nNOS from PSD-95 promotes functional recovery after cerebral ischaemia in mice through reducing excessive tonic GABA release from reactive astrocytes.

机构信息

Department of Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, PR China.

Laboratory of Cerebrovascular Disease, Nanjing Medical University, Nanjing, PR China.

出版信息

J Pathol. 2018 Feb;244(2):176-188. doi: 10.1002/path.4999. Epub 2017 Dec 29.

Abstract

Mechanisms underlying functional recovery after stroke are little known, and effective drug intervention during the delayed stage is desirable. One potential drug target, the protein-protein interaction between neuronal nitric oxide synthase (nNOS) and postsynaptic density protein 95 (PSD-95), is critical to acute ischaemic damage and neurogenesis. We show that nNOS-PSD-95 dissociation induced by microinjection of a recombinant fusion protein, Tat-nNOS-N , or systemic administration of a small-molecule, ZL006, from day 4 to day 10 after photothrombotic ischaemia in mice reduced excessive tonic inhibition in the peri-infarct cortex and ameliorated motor functional outcome. We also demonstrated improved neuroplasticity including increased dendrite spine density and synaptogenesis after reducing excessive tonic inhibition by nNOS-PSD-95 dissociation. Levels of gamma-aminobutyric acid (GABA) and GABA transporter-3/4 (GAT-3/4) are increased in the reactive astrocytes in the peri-infarct cortex. The GAT-3/4-selective antagonist SNAP-5114 reduced tonic inhibition and promoted function recovery, suggesting that increased tonic inhibition in the peri-infarct cortex was due to GABA release from reversed GAT-3/4 in reactive astrocytes. Treatments with Tat-nNOS-N or ZL006 after ischaemia inhibited astrocyte activation and GABA production, prevented the reversal of GAT-3/4, and consequently decreased excessive tonic inhibition and ameliorated functional outcome. The underlying molecular mechanisms were associated with epigenetic inhibition of glutamic acid decarboxylase 67 and monoamine oxidase B expression through reduced NO production. The nNOS-PSD-95 interaction is thus a potential target for functional restoration after stroke and ZL006, a small molecule inhibitor of this interaction, is a promising pharmacological lead compound. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

摘要

脑卒中后功能恢复的机制尚不清楚,延迟期有效的药物干预是可取的。神经元型一氧化氮合酶(nNOS)与突触后密度蛋白 95(PSD-95)之间的蛋白-蛋白相互作用是一种潜在的药物靶点,对于急性缺血损伤和神经发生至关重要。我们发现,在光血栓性缺血后 4 至 10 天,通过微注射重组融合蛋白 Tat-nNOS-N 或全身给予小分子 ZL006,诱导 nNOS-PSD-95 解离,可减少梗死周边皮层过度紧张性抑制,改善运动功能。我们还证明,通过减少 nNOS-PSD-95 解离引起的过度紧张性抑制,可改善神经可塑性,包括增加树突棘密度和突触形成。在梗死周边皮层的反应性星形胶质细胞中,γ-氨基丁酸(GABA)和 GABA 转运体-3/4(GAT-3/4)的水平增加。GAT-3/4 选择性拮抗剂 SNAP-5114 减少紧张性抑制并促进功能恢复,表明梗死周边皮层中过度紧张性抑制是由于 GABA 从反应性星形胶质细胞中的逆向 GAT-3/4 释放引起的。缺血后用 Tat-nNOS-N 或 ZL006 治疗可抑制星形胶质细胞激活和 GABA 产生,防止 GAT-3/4 的逆转,从而减少过度紧张性抑制并改善功能结局。潜在的分子机制与通过减少 NO 产生,对谷氨酸脱羧酶 67 和单胺氧化酶 B 表达的表观遗传抑制有关。因此,nNOS-PSD-95 相互作用是脑卒中后功能恢复的潜在靶点,ZL006 是该相互作用的小分子抑制剂,是一种有前途的药理学先导化合物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验